Tomoaki Murakami Selected Research

Retinal Arterial Macroaneurysm

3/2022	Retinal arterial macroaneurysm rupture caused by dissection-like change in the vessel wall.
9/2021	Hemodynamic and structural changes in retinal arterial macroaneurysm after intravitreal anti-vascular endothelial growth factor injection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomoaki Murakami Research Topics

Disease

39	Macular Edema 05/2022 - 08/2006
26	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 03/2005
22	Retinal Vein Occlusion 01/2022 - 08/2006
15	Amyloidosis 01/2022 - 09/2011
7	Heart Failure 01/2018 - 05/2002
7	Retinal Detachment (Retinal Detachments) 05/2014 - 02/2011
6	Amyloid Plaque 01/2022 - 03/2012
5	Congenital Heart Defects (Congenital Heart Defect) 05/2019 - 03/2004
4	Neoplasms (Cancer) 07/2022 - 09/2012
4	Fibrosis (Cirrhosis) 07/2021 - 03/2015
4	Inflammation (Inflammations) 11/2020 - 10/2015
4	Epiretinal Membrane (Epiretinal Membranes) 07/2015 - 09/2011
3	Hemorrhage 01/2022 - 01/2015
3	Infections 11/2020 - 09/2011
3	Hypertension (High Blood Pressure) 01/2020 - 02/2007
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 11/2016
3	Retinal Neovascularization 12/2006 - 08/2005
2	Retinal Arterial Macroaneurysm 03/2022 - 09/2021
2	Pathologic Constriction (Stenosis) 01/2021 - 10/2017
2	Cerebral Infarction 01/2021 - 12/2019
2	Aneurysm (Aneurysms) 01/2020 - 12/2015
2	Neuroinflammatory Diseases 01/2019 - 01/2019
2	Vision Disorders (Hemeralopia) 12/2016 - 01/2013
2	Proteostasis Deficiencies 11/2016 - 01/2015
2	Bacterial Infections (Bacterial Infection) 10/2015 - 06/2013
2	Aortic Coarctation 03/2015 - 12/2008
2	Microcephaly 05/2014 - 04/2014
2	Microaneurysm 04/2013 - 02/2011
2	Vitreous Detachment (Posterior Vitreous Detachment) 01/2013 - 10/2007
2	Tetralogy of Fallot (Fallot Tetralogy) 02/2012 - 04/2005
2	Pathologic Neovascularization 09/2007 - 01/2006
2	Ischemia 09/2007 - 08/2005
2	Pulmonary Artery Stenosis 02/2006 - 04/2005
1	Rhabdomyosarcoma 07/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2021
1	Disease Progression 07/2021
1	Hematoma 07/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 06/2021
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021
1	Nasal Obstruction 01/2021
1	Psoriatic Arthritis 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Wilms Tumor (Wilm's Tumor) 03/2020

Drug/Important Bio-Agent (IBA)

38	Retinaldehyde (Retinal)IBA 03/2022 - 08/2005
17	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 03/2005
15	Amyloid (Amyloid Fibrils)IBA 01/2022 - 03/2012
12	Ranibizumab (Lucentis)FDA Link 05/2022 - 01/2015
12	AA amyloidosisIBA 06/2021 - 09/2011
8	Fluorescein (Funduscein)FDA LinkGeneric 06/2021 - 12/2010
7	Biomarkers (Surrogate Marker)IBA 07/2021 - 03/2015
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2015
5	N-acetyltryptophanamide (NATA)IBA 05/2022 - 01/2017
4	Amyloidogenic ProteinsIBA 01/2022 - 09/2011
4	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2009 - 08/2006
3	Congo RedIBA 01/2022 - 11/2016
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2018
3	AntioxidantsIBA 04/2019 - 10/2017
3	Tolvaptan FDA Link 02/2016 - 06/2013
3	Bevacizumab (Avastin)FDA Link 10/2012 - 11/2010
2	SteroidsIBA 01/2021 - 09/2013
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2020 - 11/2016
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 11/2020 - 11/2016
2	VimentinIBA 03/2020 - 09/2012
2	AutoantibodiesIBA 01/2019 - 01/2019
2	Fibroins (Fibroin)IBA 11/2017 - 11/2016
2	Vasopressins (Vasopressin)IBA 02/2016 - 06/2013
2	Coenzyme A (CoA)IBA 03/2015 - 12/2008
2	Alkylating AgentsIBA 05/2014 - 04/2014
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 05/2014 - 04/2014
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2013 - 02/2012
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 09/2007 - 08/2005
2	Erythropoietin FDA Link 09/2007 - 08/2005
1	Extracellular Matrix ProteinsIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	fibulinIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 07/2021
1	EdaravoneIBA 07/2021
1	Antineoplastic Agents (Antineoplastics)IBA 07/2021
1	OxazoloneIBA 06/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	SynucleinsIBA 01/2021
1	Ointments (Pastes)IBA 01/2021
1	Infliximab (Remicade)FDA Link 01/2021
1	Keratins (Keratin)IBA 03/2020

Therapy/Procedure

10	Injections 05/2022 - 12/2016
10	Therapeutics 01/2021 - 05/2012
7	Lasers (Laser) 01/2022 - 06/2014
5	Aftercare (After-Treatment) 03/2022 - 01/2011
5	Vitrectomy 01/2018 - 09/2012
3	Thrombectomy 01/2021 - 12/2015
2	Catheters 01/2022 - 02/2006
2	Fontan Procedure (Fontan Operation) 01/2018 - 02/2006
2	Intravitreal Injections 01/2018 - 04/2009
2	Stents 10/2017 - 04/2005
1	Radiotherapy 07/2022
1	Mastoidectomy 07/2022
1	Drug Therapy (Chemotherapy) 07/2022
1	Surgical Instruments (Clip) 07/2021
1	Ligation 01/2021
1	Local Anesthesia 01/2021